1-100235416-CT-CTT

Variant summary

Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2

The NM_001918.5(DBT):​c.251+19dupA variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00897 in 1,272,154 control chromosomes in the GnomAD database, including 76 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0084 ( 11 hom., cov: 32)
Exomes 𝑓: 0.0090 ( 65 hom. )

Consequence

DBT
NM_001918.5 intron

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -4.06
Variant links:
Genes affected
DBT (HGNC:2698): (dihydrolipoamide branched chain transacylase E2) The branched-chain alpha-keto acid dehydrogenase complex (BCKD) is an inner-mitochondrial enzyme complex involved in the breakdown of the branched-chain amino acids isoleucine, leucine, and valine. The BCKD complex is thought to be composed of a core of 24 transacylase (E2) subunits, and associated decarboxylase (E1), dehydrogenase (E3), and regulatory subunits. This gene encodes the transacylase (E2) subunit. Mutations in this gene result in maple syrup urine disease, type 2. Alternatively spliced transcript variants have been described, but their biological validity has not been determined. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -16 ACMG points.

BP6
Variant 1-100235416-C-CT is Benign according to our data. Variant chr1-100235416-C-CT is described in ClinVar as [Likely_benign]. Clinvar id is 93998.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00844 (1283/152046) while in subpopulation NFE AF= 0.0134 (911/67942). AF 95% confidence interval is 0.0127. There are 11 homozygotes in gnomad4. There are 599 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 11 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DBTNM_001918.5 linkc.251+19dupA intron_variant Intron 3 of 10 ENST00000370132.8 NP_001909.4 P11182

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DBTENST00000370132.8 linkc.251+19_251+20insA intron_variant Intron 3 of 10 1 NM_001918.5 ENSP00000359151.3 P11182

Frequencies

GnomAD3 genomes
AF:
0.00845
AC:
1284
AN:
151928
Hom.:
11
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00186
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0100
Gnomad ASJ
AF:
0.00751
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00228
Gnomad FIN
AF:
0.00777
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.0134
Gnomad OTH
AF:
0.0101
GnomAD3 exomes
AF:
0.00857
AC:
2110
AN:
246188
Hom.:
16
AF XY:
0.00876
AC XY:
1165
AN XY:
132960
show subpopulations
Gnomad AFR exome
AF:
0.00137
Gnomad AMR exome
AF:
0.00462
Gnomad ASJ exome
AF:
0.00726
Gnomad EAS exome
AF:
0.0000554
Gnomad SAS exome
AF:
0.00266
Gnomad FIN exome
AF:
0.00857
Gnomad NFE exome
AF:
0.0137
Gnomad OTH exome
AF:
0.0107
GnomAD4 exome
AF:
0.00904
AC:
10130
AN:
1120108
Hom.:
65
Cov.:
16
AF XY:
0.00916
AC XY:
5245
AN XY:
572618
show subpopulations
Gnomad4 AFR exome
AF:
0.00131
Gnomad4 AMR exome
AF:
0.00491
Gnomad4 ASJ exome
AF:
0.00706
Gnomad4 EAS exome
AF:
0.0000265
Gnomad4 SAS exome
AF:
0.00294
Gnomad4 FIN exome
AF:
0.00927
Gnomad4 NFE exome
AF:
0.0106
Gnomad4 OTH exome
AF:
0.00825
GnomAD4 genome
AF:
0.00844
AC:
1283
AN:
152046
Hom.:
11
Cov.:
32
AF XY:
0.00806
AC XY:
599
AN XY:
74348
show subpopulations
Gnomad4 AFR
AF:
0.00186
Gnomad4 AMR
AF:
0.0100
Gnomad4 ASJ
AF:
0.00751
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00228
Gnomad4 FIN
AF:
0.00777
Gnomad4 NFE
AF:
0.0134
Gnomad4 OTH
AF:
0.00995
Alfa
AF:
0.0139
Hom.:
10
Bravo
AF:
0.00742
Asia WGS
AF:
0.00231
AC:
8
AN:
3472

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
May 12, 2016
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Oct 30, 2013
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Maple syrup urine disease Benign:2
Apr 11, 2023
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Feb 01, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Maple syrup urine disease type 1A Benign:1
Sep 21, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs201469612; hg19: chr1-100700972; API